Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001415889-25-010879

VP, Clinical Trial Operations acquired 13,350 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Yu Yong VP, Clinical Trial Operations 2025-03-14 Grant or award +13,350 53,219 D
Loading xslF345X05/form4-04172025_080423.xml…